Results 1 to 10 of about 9,601 (224)
CD8+T-bet+ cells as a predominant biomarker for inclusion body myositis
Autoimmunity Reviews, 2019 International audienceBackground: Myositis is a heterogeneous group of muscular auto-immune diseases with clinical and pathological criteria that allow the classification of patients into different sub-groups. Inclusion body myositis is the most frequent
Gaëlle Dzangue-Tchoupou +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Inclusion body myositis in an older patient following a fall
Clinical Case Reports, 2023 Key Clinical Message After experiencing a fall, an 82‐year‐old woman developed progressive loss of lower limb strength and was diagnosed with inclusion body myositis.
Haruma Saiki +5 more
doaj +2 more sources
Biology of Sport, 2014 Inclusion body myositis is a rare idiopathic inflammatory myopathy that produces extreme muscle weakness. Blood flow restricted resistance training has been shown to improve muscle strength and muscle hypertrophy in inclusion body myositis.
A.R. Santos +7 more
doaj +2 more sources
Seminars in Neurology, 2012 The idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of rare disorders that share many similarities. In addition to sporadic inclusion body myositis (IBM), these include dermatomyositis, polymyositis, and autoimmune necrotizing myopathy. IBM is the most common IIM after age 50 years.
Richard Barohn, Mazen M Dimachkie
exaly +7 more sources
Obturator hernia associated with inclusion body myositis: a case report [PDF]
Journal of Medical Case ReportsBackground Inclusion body myositis is a progressive muscle disease characterized by weakness, specifically in the flexor digitorum profundus and quadriceps muscles, and commonly affects men over 50 years of age.
Yuma Sato +3 more
doaj +2 more sources